Clinical Trials Logo

Clinical Trial Summary

This 12-week randomized, open-label study evaluates the efficacy and safety of Tacrolimus for Sjogren's syndrome patients with thrombocytopenia.


Clinical Trial Description

This study evaluates the efficacy and safety of Tacrolimus for the treatment of thrombocytopenia in Sjogren's syndrome patients. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05678335
Study type Interventional
Source Peking Union Medical College Hospital
Contact Hua Chen, Dr.
Phone 861069159962
Email chenhua@pumch.cn
Status Not yet recruiting
Phase Phase 2/Phase 3
Start date February 2023
Completion date March 2024